Main Content

“2020health is an important and thoughtful contributor to the health debate”

Dr Sarah Wollaston MP, Chairman, Health Select Committee


Next steps for NICE, priorities for the pharmaceutical industry, and the Accelerated Access Review

Jan 14. till Jan 14.

With guest speaker: Julia Manning, CEO, 2020health

Westminster Health Forum Keynote Seminar

With Guest of Honour: Professor Gillian Leng, Deputy Chief Executive and Director of Health and Social Care, NICE

Attendees at this seminar will discuss priorities for NICE moving into 2016 and beyond, and the key challenges facing the pharmaceutical industry.

They will assess the impact and role of NICE guidelines in health and social care provision, and priorities for the development of further guideline frameworks for public health.

There will also be discussion on recommendations of the Accelerated Access Review, the future for the Cancer Drugs Fund, and key issues regarding market access, evaluation, pricing and commissioning of pharmaceuticals.

Julia will be speaking on 'The future for the Cancer Drugs Fund: access, value and evidence based strategies'

January 14, 20162016-01-14T09:00:28 - January 14, 2016 2016-01-14T01:00:00
9:00 AM 2016-01-14T09:00:28 - 1:00 PM 2016-01-14T01:00:00
Central London
Full details & Registration